G.E.R.N. Center for Tissue Replacement, Regeneration & Neogenesis, Department of Orthopedics and Trauma Surgery, Faculty of Medicine, Medical Center-Albert-Ludwigs-University of Freiburg, 79085 Freiburg im Breisgau, Germany.
Int J Mol Sci. 2021 Jul 27;22(15):8005. doi: 10.3390/ijms22158005.
Inflammation plays a central role in the pathogenesis of knee PTOA after knee trauma. While a comprehensive therapy capable of preventing or delaying post-traumatic osteoarthritis (PTOA) progression after knee joint injury does not yet clinically exist, current literature suggests that certain aspects of early post-traumatic pathology of the knee joint may be prevented or delayed by anti-inflammatory therapeutic interventions. We discuss multifaceted therapeutic approaches that may be capable of effectively reducing the continuous cycle of inflammation and concomitant processes that lead to cartilage degradation as well as those that can simultaneously promote intrinsic repair processes. Within this context, we focus on early disease prevention, the optimal timeframe of treatment and possible long-lasting sustained delivery local modes of treatments that could prevent knee joint-associated PTOA symptoms. Specifically, we identify anti-inflammatory candidates that are not only anti-inflammatory but also anti-degenerative, anti-apoptotic and pro-regenerative.
炎症在膝关节创伤后膝 PTOA 的发病机制中起核心作用。虽然一种能够预防或延迟膝关节损伤后创伤后骨关节炎 (PTOA) 进展的综合疗法尚未在临床上出现,但目前的文献表明,通过抗炎治疗干预可能预防或延迟膝关节创伤后早期病理的某些方面。我们讨论了多方面的治疗方法,这些方法可能能够有效地减少炎症的持续循环以及导致软骨降解的伴随过程,以及那些能够同时促进内在修复过程的方法。在这方面,我们专注于早期疾病预防、治疗的最佳时间框架以及可能长期持续的局部治疗方式,以预防膝关节相关 PTOA 症状。具体来说,我们确定了不仅具有抗炎作用,而且具有抗退化、抗凋亡和促再生作用的抗炎候选物。